pantoprazole has been researched along with n,n-dimethylarginine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bednarek, J; Chyrchel, B; Kruszelnicka, O; Nessler, J; Surdacki, A; Świerszcz, J | 1 |
| Abo-Saif, AA; Mohamed, WR; Mohamed, YT; Naguib, IA | 1 |
2 other study(ies) available for pantoprazole and n,n-dimethylarginine
| Article | Year |
|---|---|
Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Arginine; Coronary Artery Disease; Cross-Sectional Studies; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 2016 |
Protective effects of perindopril against indomethacin-induced gastric mucosal damage through modulation of DDAH-1/ADMA and ACE-2/ANG-(1-7) signaling pathways.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cyclooxygenase 2; Indomethacin; Pantoprazole; Perindopril; Prostaglandins E; Rats; Signal Transduction; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2022 |